Study links acid-reducing drugs to increased risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

MPH Health Care AG (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: MPH Health Care AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu MPH Health Care AG Unternehmen:

July 11, 2023

Aridis to delist from Nasdaq; Bicycle closes $200M+ offering

Aridis Pharmaceuticals is being taken off the Nasdaq, effective Wednesday. The biotech reported the news in an SEC filing Monday, saying that it will be

July 19, 2023

Meta Title: “Forma Therapeutics Inc Files Patent for USP30 Inhibitor Compounds

Share this article According to GlobalData’s company profile on Forma Therapeutics, Cancer treatment biomarkers was a key innovation area identified from patents. Forma Therapeutics‘s grant

April 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.